Acute Effects of L-Theanine and L-Tyrosine on Cognitive and Archery Performance (THEA-TYR)
Acute Effects of L-Theanine, L-Tyrosine, and Combined Supplementation on Cognitive and Archery Performance: A Randomized, Placebo-Controlled Crossover Study
This study aims to investigate the acute effects of L-theanine, L-tyrosine, and their combination on cognitive performance and archery performance in trained archers. The study will use a randomized, placebo-controlled, five-condition crossover design involving 21 healthy male archers aged 18 years or older.
Participants will complete five experimental conditions: placebo, L-theanine supplementation (6 mg/kg), L-tyrosine supplementation (50 mg/kg), combined L-theanine and L-tyrosine supplementation, and a no-supplement control condition. Supplements will be administered 60 minutes before performance assessments, with at least 72 hours between experimental sessions.
Cognitive performance will be assessed using the Stroop Test, while archery performance will be evaluated through indoor target shooting at 18 meters. Mood states and perceived exertion will also be assessed using the BRUMS questionnaire and Borg CR-10 scale, respectively.
The study will examine whether these supplementation conditions produce different acute responses in cognitive function and archery performance.
調査の概要
状態
研究の種類
入学 (推定)
段階
- 適用できない
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- 1. Being 18 years of age or older. 2. Being a healthy male individual. 3. Having at least five years of regular archery experience. 4. Training in archery at least three days per week. 5. Having national or international competition experience in archery. 6. Voluntarily agreeing to participate in the study.
Exclusion Criteria:
-
1. Having a medical condition that may interfere with participation in the study.
2. Having a known allergy or hypersensitivity to L-theanine or L-tyrosine. 3. Using medications or supplements that may affect cognitive or physical performance during the study period.
4. Being unable to complete all five experimental sessions. 5. Failing to comply with the study procedures.
研究計画
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：基礎科学
- 割り当て：ランダム化
- 介入モデル：クロスオーバー割り当て
- マスキング：なし（オープンラベル）
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Five-Condition Crossover Group
All participants will complete five experimental conditions in a randomized crossover design: placebo, L-theanine, L-tyrosine, combined L-theanine and L-tyrosine, and no-supplement control. Each participant will receive all five conditions, with at least 72 hours of washout between sessions. |
Participants will receive a placebo 60 minutes before performance assessments. The placebo will be prepared in a form identical to the active supplementation capsules to maintain blinding. Participants will receive L-theanine at a dose of 6 mg/kg body weight, administered 60 minutes before performance assessments. Participants will receive L-tyrosine at a dose of 50 mg/kg body weight, administered 60 minutes before performance assessments. Participants will receive a combination of L-theanine (6 mg/kg body weight) and L-tyrosine (50 mg/kg body weight), administered together 60 minutes before performance assessments. Participants will complete the performance assessments without receiving any supplementation during this condition. This condition will serve as the no-supplement control for comparison with the placebo and active supplementation conditions. |
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Total Archery Shooting Score
時間枠：Immediately after the archery shooting task in each experimental session (approximately 60 minutes after supplement or placebo administration).
|
Archery performance will be assessed by recording the total score obtained from 15 arrows (5 sets of 3 arrows) shot at an indoor target from a distance of 18 meters using a 40-cm target face. Higher scores indicate better archery performance. |
Immediately after the archery shooting task in each experimental session (approximately 60 minutes after supplement or placebo administration).
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。